Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04098146 · ClinicalTrials.gov registry record
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis
A clinical trial of Mandibular Reconstruction and Segmental Mandibular Defects, sponsored by AO Innovation Translation Center.
- Recruiting
- Registry status
- 300
- Enrollment target
- 19
- Study locations
NCT04098146: Recruiting study of Mandibular Reconstruction and Segmental Mandibular Defects, sponsored by AO Innovation Translation Center.
NCT04098146 is a study of Mandibular Reconstruction and Segmental Mandibular Defects that is actively recruiting participants, run by AO Innovation Translation Center. The registered enrollment target is 300 participants. The trial reports 19 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04098146, a study of Mandibular Reconstruction and Segmental Mandibular Defects, is actively recruiting participants, sponsored by AO Innovation Translation Center.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 19
- Study locations
Study Summary
Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.
Primary Outcome
Demographics (year of birth, height in cm and weight in kilogram, race)
Conditions Studied
Interventions
- PROCEDURE Surgical Resection and Reconstruction
Study Locations (19)
Other
- University Hospital RWTH Aachen - Aachen
- University Hospital Charité - Berlin
- Hannover Medical School - Hanover
- Universitätsklinikum Heidelberg - Heidelberg
- University Hospital Leipzig - Leipzig
- Klinikum der LMU München - Munich
- University Hospital Ulm - Ulm
- Shimane University - Izumo
- Erasmus University Medical Centre - Rotterdam
- Luz Hospital - Lisbon
- 12 de Octubre - Madrid
- Uppsala University Hospital - Uppsala
- University Hospital Basel - Basel
New York
- Northwell Health Cancer Institute - New Hyde Park
- Mount Sinai Hospital - New York
Florida
- University of Florida College of Medicine - Jacksonville
Illinois
- University of Illinois Chicago - Chicago
Texas
- John Peter Smith Health Network - Fort Worth
Baden-Wurttemberg
- Universitätsklinikum Tübingen - Tübingen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2030-12-31 |
What NCT04098146 shows while recruiting
NCT04098146 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Mandibular Reconstruction appearing as the primary indexed condition, and to 1 intervention - of which Surgical Resection and Reconstruction is the first listed.
NCT04098146 lists 19 locations in 6 states (Other, New York, Florida).
Frequently Asked Questions
What is clinical trial NCT04098146 about?
NCT04098146 is a clinical study titled "Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis". Prospective will be collected in a minimum of 300 patients presenting with an acquired segmental mandibular defect ≥ 2 cm secondary to OSSC removal and drugs-induced osteonecrosis, and who require mandibular reconstruction.
What is the current status of trial NCT04098146?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2022-09-12. Estimated completion is 2030-12-31.
What conditions does trial NCT04098146 study?
This clinical trial studies the following conditions: Mandibular Reconstruction, Segmental Mandibular Defects.
What interventions are being tested in trial NCT04098146?
The interventions under investigation include: Surgical Resection and Reconstruction (PROCEDURE).
Who is sponsoring clinical trial NCT04098146?
This trial is sponsored by AO Innovation Translation Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04098146 being conducted?
This trial has 19 study locations across Florida, Illinois, New York, Texas, Baden-Wurttemberg. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mandibular Reconstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI